Nu SkinNUS
NUS
About: Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Employees: 11,300
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
980% more call options, than puts
Call options by funds: $324K | Put options by funds: $30K
33% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 58
7% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 41
2% less funds holding
Funds holding: 203 [Q3] → 199 (-4) [Q4]
2.22% less ownership
Funds ownership: 77.81% [Q3] → 75.59% (-2.22%) [Q4]
9% less capital invested
Capital invested by funds: $285M [Q3] → $259M (-$26.2M) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for NUS.
Financial journalist opinion
Neutral
Business Wire
4 weeks ago
Nu Skin Enterprises to Announce First Quarter 2025 Financial Results
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2025 results after the market closes on Thursday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor.
Positive
Zacks Investment Research
1 month ago
5 Value Stocks With Exciting EV-to-EBITDA Ratios to Scoop Up
We have screened value stocks OPFI, NUS, BJRI, MRC and KT based on the EV-to-EBITDA ratio, which gives the true picture of valuation and earnings potential.
Positive
Zacks Investment Research
2 months ago
Top Beauty and Cosmetics Stocks in Focus Right Now
Beauty and Cosmetics stocks like NUS, ULTA and SBH are thriving on innovation, digital engagement and strategic expansions.
Positive
Zacks Investment Research
2 months ago
Don't Overlook These Top Dividend Stocks Under $20: KT, PAX, NUS
Here are three top-rated Zacks stocks to consider under $20 with generous dividends.
Positive
Zacks Investment Research
2 months ago
Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year?
Here is how Nu Skin Enterprises (NUS) and Primo Brands (PRMB) have performed compared to their sector so far this year.
Neutral
Zacks Investment Research
2 months ago
5 High Earnings Yield Value Stocks to Buy Amid Market Volatility
Volatility looms with sticky inflation, a slowing economy and Trump's trade policies. Buy high-earnings-yield stocks like NUS, HRMY, PAHC, DAN and NRG.
Positive
Zacks Investment Research
2 months ago
Nu Skin Q4 Earnings Beat Estimates, Rhyz Revenues Increase Y/Y
NUS Q4 results reflect lower revenues and higher earnings. The adjusted operating margin expands 130 bps y/y.
Neutral
Seeking Alpha
2 months ago
Nu Skin Enterprises, Inc. (NUS) Q4 2024 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants B.G. Hunt - Head of Investor Relations Ryan Napierski - President & Chief Executive Officer James Thomas - Chief Financial Officer Conference Call Participants Sydney Wagner - Jefferies Christina Xue - D.A.
Positive
Zacks Investment Research
2 months ago
Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Top Estimates
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.37 per share a year ago.
Neutral
Business Wire
2 months ago
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2024 results above its latest revenue guidance. Executive Summary Q4 2024 vs. Prior-year Quarter Revenue $445.6 million; (8.8)% (4.1)% FX impact or $(20.1) million Rhyz revenue $83.1 million; 27.7% Earnings Per Share (EPS) $(0.73) or $0.38 excluding restructuring and other charges, compared to $0.15 or $0.37 excluding restructuring and other charges Customers 831,972; (15)% Paid Affil.
Charts implemented using Lightweight Charts™